The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer

• Chiara Lucchetti,

  Affiliation Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, United States of America

  ⨯
• Isabella Caligiuri,

  Affiliations Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, United States of America, Human Health Foundation, Terni and Spoleto (PG), Italy, Department of Human Pathology and Oncology, University of Siena, Siena (SI), Italy

  ⨯
• Giuseppe Toffoli,

  Affiliation Division of Experimental and Clinical Pharmacology, Department of Molecular Biology and Translational Research, National Cancer Institute and Center for Molecular Biomedicine, Aviano (PN), Italy

  ⨯
• Antonio Giordano ,

  * E-mail: giordano@temple.edu(AG); rizzolio@temple.edu (FR)

  Affiliations Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, United States of America, Human Health Foundation, Terni and Spoleto (PG), Italy, Department of Human Pathology and Oncology, University of Siena, Siena (SI), Italy

  ⨯
• Flavio Rizzolio

  * E-mail: giordano@temple.edu(AG); rizzolio@temple.edu (FR)

  Affiliations Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, United States of America, Division of Experimental and Clinical Pharmacology, Department of Molecular Biology and Translational Research, National Cancer Institute and Center for Molecular Biomedicine, Aviano (PN), Italy

  ⨯